Arizona Doc's DEA License Revoked Over State Snub
Published Date: 7/14/2025
Notice
Summary
Elias Garcia Garcia, P.A., a medical professional in Arizona, lost the right to handle controlled substances because he no longer has state permission to do so. The DEA tried to notify him, but he didn’t ask for a hearing, so his registration was revoked by default. This means he can’t legally prescribe or dispense certain drugs anymore, effective immediately.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 2 costs, 1 mixed.
DEA Registration Revoked for Named Practitioner
The Drug Enforcement Administration revoked DEA Certificate of Registration No. MG8041206 issued to Elias Garcia Garcia, P.A., because he is not currently authorized by Arizona law to handle controlled substances. The revocation takes effect on August 13, 2025, and means the registrant cannot legally prescribe, administer, dispense, or otherwise handle controlled substances in Arizona under that DEA registration number.
Pending Renewal and New DEA Applications Denied
DEA denied any pending applications by Elias Garcia Garcia, P.A., to renew or modify Certificate No. MG8041206 and denied any other pending applications for additional registration in Arizona. This denial is ordered along with the revocation and is effective as part of the same Order.
Opportunity to Seek Reconsideration Within 15 Days
The Order allows Elias Garcia Garcia, P.A., to file a properly supported motion for reconsideration of the factual findings within fifteen calendar days of the date of the Order. Any such motion and responses must be filed and served by email to the other party and to the Office of the Administrator at the address provided in the Order.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20552, Wellwise Pharmacy Inc.; Decision and Order
Wellwise Pharmacy in Texas had its DEA registration suspended and is facing revocation because it kept filling risky prescriptions for controlled drugs without checking warning signs. This affects the pharmacy’s ability to legally handle these medicines, protecting public health and safety. The decision took effect immediately in late 2025, stopping Wellwise from operating under its DEA license and signaling serious legal and financial trouble ahead.
2026-20535, Arenbii Pharmacy LLC; Decision and Order
Arenbii Pharmacy in Texas lost its DEA license because it kept filling risky drug prescriptions without fixing obvious problems. This means they can’t legally handle certain controlled medicines anymore, protecting public safety. The decision is final, and Arenbii didn’t ask for a hearing, so the revocation starts now with no chance to appeal.
Previous / Next Documents
Previous: 2025-13118, Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (PRWORA); Interpretation of “Federal Public Benefit”
This update explains what counts as a “Federal public benefit” under a 1996 law that affects who can get certain government help. It changes and expands the list of health and social programs covered, making it clearer who qualifies or doesn’t. These changes help make sure benefits go to the right people and could affect access starting now.
Next: 2025-13121, JYA LLC d/b/a Webb's Square Pharmacy; Decision and Order
Webb's Square Pharmacy in Florida lost its DEA license because it gave out controlled medicines without proper prescriptions from July 2021 to March 2024. The pharmacy didn’t respond to the government’s warnings, so their registration was suspended and then revoked to protect public safety. This means they can’t legally handle controlled drugs anymore, effective immediately, impacting their business and customers.